EMEA-001652-PIP01-14-M03

Table of contents

Key facts

Invented name
Reagila
Active substance
Cariprazine (hydrochloride)
Therapeutic area
Psychiatry
Decision number
P/0105/2021
PIP number
EMEA-001652-PIP01-14-M03
Pharmaceutical form(s)
Capsule, hard
Condition(s) / indication(s)
Treatment of schizophrenia
Route(s) of administration
Oral use
Contact for public enquiries
Decision type
RPM: decision refers to a refusal on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating
Average
1 rating